Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
22 Apr 24
DEFA14A
Additional proxy soliciting materials
22 Apr 24
DEF 14A
Definitive proxy
22 Apr 24
S-8
Registration of securities for employees
5 Mar 24
10-K
2023 FY
Annual report
5 Mar 24
8-K
NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million
5 Mar 24
8-K
Departure of Directors or Certain Officers
7 Feb 24
8-K
NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates
8 Jan 24
8-K
Entry into a Material Definitive Agreement
4 Dec 23
10-Q
2023 Q3
Quarterly report
6 Nov 23
8-K
NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
6 Nov 23
S-8
Registration of securities for employees
8 Aug 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
8-K
NeuroPace Reports Second Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
8 Aug 23
8-K
Departure of Directors or Certain Officers
19 Jul 23
8-K
Departure of Directors or Certain Officers
28 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
12 Jun 23
10-Q
2023 Q1
Quarterly report
4 May 23
8-K
NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
4 May 23
ARS
2022 FY
Annual report to shareholders
25 Apr 23
DEFA14A
Additional proxy soliciting materials
25 Apr 23
DEF 14A
Definitive proxy
25 Apr 23
8-K
Departure of Directors or Certain Officers
13 Apr 23
S-8
Registration of securities for employees
2 Mar 23
10-K
2022 FY
Annual report
2 Mar 23
8-K
NeuroPace Reports Fourth Quarter & Full Year 2022 Financial Results
2 Mar 23
8-K
NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of Directors
9 Jan 23
EFFECT
Notice of effectiveness
23 Nov 22
S-3
Shelf registration
8 Nov 22
10-Q
2022 Q3
Quarterly report
8 Nov 22
8-K
NeuroPace Reports Third Quarter 2022 Financial Results and Provides a Business Update
8 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
8-K
NeuroPace Reports Second Quarter 2022 Financial Results and Provides a Business Update
11 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
17 Jun 22
10-Q
2022 Q1
Quarterly report
12 May 22
8-K
NeuroPace Reports First Quarter 2022 Financial Results
12 May 22
DEFA14A
Additional proxy soliciting materials
22 Apr 22
DEF 14A
Definitive proxy
22 Apr 22
S-8
Registration of securities for employees
10 Mar 22
10-K
2021 FY
Annual report
10 Mar 22
Latest ownership filings
4
Change in insider ownership
3 May 24
4
Change in insider ownership
26 Apr 24
4
Change in insider ownership
23 Apr 24
4
Change in insider ownership
18 Apr 24
4
Change in insider ownership
15 Apr 24
144
Notice of proposed sale of securities
15 Mar 24
4
Martha Morrell
28 Feb 24
4
Rebecca Kuhn
28 Feb 24
4
Joel Becker
28 Feb 24
SC 13G/A
ORBIMED ADVISORS LLC
14 Feb 24
SC 13G/A
KCK LTD.
14 Feb 24
SC 13G/A
MORGAN STANLEY
9 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
4
Martha Morrell
6 Feb 24
SC 13G/A
Soleus Private Equity Fund I, L.P.
2 Feb 24
4
Martha Morrell
1 Feb 24
4
Martha Morrell
26 Jan 24
4
Martha Morrell
28 Dec 23
4
Martha Morrell
22 Dec 23
144
Notice of proposed sale of securities
20 Dec 23
4
Martha Morrell
7 Dec 23
144
Notice of proposed sale of securities
6 Dec 23
4
Change in insider ownership
1 Dec 23
4
Change in insider ownership
29 Nov 23
144
Notice of proposed sale of securities
29 Nov 23
4
Change in insider ownership
4 Oct 23
144
Notice of proposed sale of securities
2 Oct 23
4
Joel Becker
19 Jul 23
3
Joel Becker
19 Jul 23
4
Lisa Andrade
14 Jun 23
4
Frank M Fischer
14 Jun 23
4
Uri Geiger
14 Jun 23
4
Rakhi Kumar
14 Jun 23
4
JOSEPH LACOB
14 Jun 23
4
Renee Ryan
14 Jun 23
4
Irina Ridley
22 Feb 23
4
Rebecca Kuhn
22 Feb 23
4
Martha Morrell
22 Feb 23
4
Michael Favet
22 Feb 23
SC 13G/A
Soleus Private Equity Fund I, L.P.
14 Feb 23